Skip to content
Trial Eligibility
Menu

Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups

NCT06974773

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to learn if a wearable brain stimulation device called NettleEndo can reduce chronic pelvic pain and improve wellbeing in women with endometriosis. The study also aims to assess the safety and usability of the device when used at home over several months. The main questions it aims to answer are: Does at-home transcranial direct current stimulation (tDCS) reduce daily pain intensity in women with endometriosis? Does the device also improve mood and sleep quality?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Endometriosis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 45 years
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Samphire Group, Inc.
Last updated on ClinicalTrials.gov
December 18, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Alethios, Inc. · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.